Skip to content
Back to Blog
Government Programs
2026-05-117 min read27

2026 K-Beauty Tech Innovation R&D Expansion — 10 Companies × 500M KRW for Beauty Devices & Dermacosmetics

Korea's 2026 K-Beauty Market-Responsive R&D track expands to beauty devices and dermacosmetics. Ten companies × 500M KRW (5B KRW total)—learn the schedule, evaluation process, and proposal differentiation strategies.

KITIM Consulting Team

What Changes in 2026 K-Beauty R&D Expansion

In 2026, Korea's Ministry of SMEs and Startups is significantly expanding its 'K-Beauty Market-Responsive R&D' track. The scope of support, previously focused on functional ingredients and eco-friendly packaging, now extends to beauty devices and dermacosmetics. Ten companies will be selected to receive up to 500 million KRW each over two years (totaling 5 billion KRW). This represents approximately 22% of the total 22.3 billion KRW cosmetics R&D budget for 2026—a strategic bet aligned with K-Beauty's global expansion phase.

A particularly noteworthy shift is the formal recognition of convergence products that span medical devices and cosmetics. LED masks, RF/EMS devices, and skin diagnostic tools previously fell into a regulatory gray zone between medical device and cosmetic laws, but this reform creates an integrated R&D track.

Detailed Analysis of New Support Areas

Beauty Devices

  • LED Light Therapy: Photobiomodulation (PBM)-based skin regeneration and anti-aging
  • Radiofrequency (RF) Devices: Collagen remodeling and lifting effects
  • EMS / Microcurrent Devices: Facial muscle stimulation and contouring care
  • Skin Diagnostic Devices: AI image analysis-based skin condition measurement
  • These product categories are classified as either MFDS Class 2 medical devices or electrical appliances, and clinical trial and human application test data are required as core R&D deliverables.

    Dermacosmetics

  • Products in the boundary zone between pharmaceuticals and cosmetics
  • Mandatory clinical evidence-based efficacy verification
  • Recommended collaboration with dermatologists and acquisition of clinical pilot data
  • Examples: Madecassoside, Cica, retinol, and high-concentration niacinamide products
  • Continuing Support Areas

  • Functional new material ingredients (natural and bio-derived)
  • Eco-friendly packaging (refillable, bioplastic, paper containers)
  • Application Schedule and Evaluation Process

  • First Recruitment: January 26 – February 9, 2026 (15 days)
  • Application Channel: IRIS Integrated Management System (online)
  • Evaluation Stages: Document review → Presentation → On-site investigation → Final selection committee
  • Post-Agreement: Two-year phased milestone evaluation (mid-term review in year 1, final evaluation in year 2)
  • Funding Cap: Up to 500 million KRW per company (government contribution), with at least 25% private matching
  • K-Beauty Cluster Integration Strategy

    Within the 16.5 trillion KRW total budget of the SME Ministry for 2026, a new K-Beauty Cluster initiative has been separately funded. Tenant or partner companies of these clusters receive the following bonus points and incentives:

  • 2–3 bonus points in proposal evaluation
  • Shared prototype manufacturing infrastructure (analytical equipment, pilot production lines)
  • Matching with cluster-resident clinical trial institutions and CROs
  • Joint marketing and overseas exhibition support
  • By aligning your proposal with K-Beauty clusters in Osong, Incheon, or Seongnam, you can significantly improve selection prospects.

    Proposal Differentiation Points

    Competition is expected to exceed 10:1, and a basic technical development plan alone will not pass. Your proposal must include these four essential elements:

  • Global Market Entry Strategy: Region-specific entry scenarios for North America (Amazon, Sephora), Southeast Asia (Shopee, Lazada), and the Middle East (GCC), along with local certification plans (MoCRA, ASEAN Cosmetic Directive, SFDA)
  • Clinical & Human Application Test Data: MFDS-compliant clinical protocols, CRO agreements, and subject recruitment plans
  • ODM/OEM Partner Pre-Securing: Mass production MOUs with verified manufacturers such as Kolmar Korea and Cosmax
  • Intellectual Property Strategy: Patent filing plans for core ingredients and device mechanisms, plus prior art analysis
  • K-Beauty R&D Consulting with KITIM

    KITIM provides one-stop consulting spanning cosmetics and beauty device R&D proposal writing, regulatory approval, and global expansion.

  • K-Beauty R&D Proposal Advisory: Selection strategy development for the market-responsive track
  • Cosmetics Sales Liability & Medical Device Licensing Support: MFDS registration and clinical design assistance
  • Export Voucher & K-Brand Challenge Package Matching: Linkage to follow-on commercialization and marketing funding
  • Cluster Tenant & Partner Company Matching: Bonus point securing and infrastructure co-utilization advisory
  • Before the January 26, 2026 announcement deadline, schedule a free KITIM consultation now to determine which track best suits your K-Beauty technology. We support you from proposal drafting to presentation coaching.

    K-Beauty R&DMarket-Responsive InnovationDermacosmeticsBeauty DevicesK-Beauty Cluster

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.